New Claritis™ Solution Links PRO and Clinical Data – Representing Major Advancement in Evidence Generation for Real World Research
New Orleans, May 20, 2019: Kantar today unveiled ClaritisTM Solution, a breakthrough approach to real world data analytics. Claritis links patient reported outcomes (PRO) data and clinical data. The innovative offering represents a major advancement in evidence generation for real world research, as Claritis supports a host of evidence generation scenarios, including: providing payer agencies with the required evidence to support reimbursement decisions, supporting regulatory bodies that require evidence of real-world safety and effectiveness, and generating critical information that's used by other healthcare stakeholders, including healthcare professionals, patients and caregivers.
"When presenting the value proposition of its product to various constituents, life sciences companies need highly-accurate and timely information from both the physician’s and patient’s perspective," said Jeremy Brody, Chief Strategy Officer, for the Health Division of Kantar. "Traditionally, acquiring the necessary data has required companies to design and conduct large primary research studies or conduct multiple studies using different secondary data sources. By utilizing Claritis linked data, companies don’t have to wait for the evidence they need. Claritis provides an opportunity to examine the clinical view alongside the patient’s unique perspective, delivering significant benefits in both insights and efficiencies. Claritis is a true game changer for building strategic value with our clients."
On May 21, at ISPOR 2019, Kantar will share more detail about data linking and Claritis in an informative presentation – "Linked Data Breakthrough Delivers Major Advancement for PRO and Clinical Research". Moderated by Kantar's Lulu K. Lee, PhD, Vice President, Health Outcomes Research, and Tom Haskell, Global Head of Innovation, Data and Analytics, Kantar will share its approach for linking PRO data with more traditional real-world data, including medical and prescription claims data, electronic health records (EHRs) and lab data.
Kantar's Claritis offers a HIPAA-certified approach for linking de-identified clinical data with de-identified survey data, highly accurate probabilistic matching, and linking software validated at error rates less than industry standards.
For more information, please visit www.kantar.com/health.
New Orleans, May 20, 2019: Kantar today unveiled ClaritisTM Solution, a breakthrough approach to real world data analytics. Claritis links patient reported outcomes (PRO) data and clinical data. The innovative offering represents a major advancement in evidence generation for real world research, as Claritis supports a host of evidence generation scenarios, including: providing payer agencies with the required evidence to support reimbursement decisions, supporting regulatory bodies that require evidence of real-world safety and effectiveness, and generating critical information that's used by other healthcare stakeholders, including healthcare professionals, patients and caregivers.
"When presenting the value proposition of its product to various constituents, life sciences companies need highly-accurate and timely information from both the physician’s and patient’s perspective," said Jeremy Brody, Chief Strategy Officer, for the Health Division of Kantar. "Traditionally, acquiring the necessary data has required companies to design and conduct large primary research studies or conduct multiple studies using different secondary data sources. By utilizing Claritis linked data, companies don’t have to wait for the evidence they need. Claritis provides an opportunity to examine the clinical view alongside the patient’s unique perspective, delivering significant benefits in both insights and efficiencies. Claritis is a true game changer for building strategic value with our clients."
On May 21, at ISPOR 2019, Kantar will share more detail about data linking and Claritis in an informative presentation – "Linked Data Breakthrough Delivers Major Advancement for PRO and Clinical Research". Moderated by Kantar's Lulu K. Lee, PhD, Vice President, Health Outcomes Research, and Tom Haskell, Global Head of Innovation, Data and Analytics, Kantar will share its approach for linking PRO data with more traditional real-world data, including medical and prescription claims data, electronic health records (EHRs) and lab data.
Kantar's Claritis offers a HIPAA-certified approach for linking de-identified clinical data with de-identified survey data, highly accurate probabilistic matching, and linking software validated at error rates less than industry standards.
For more information, please visit www.kantar.com/health.